All articles from EyeWorld.org on the topic of cataract surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Floaters can impact patient perception and happiness with their vision after cataract surgery, but there is some division as to methods of treatment, especially as YAG laser vitreolysis is becoming more common. EyeWorld spoke with a cataract surgeon and two retina specialists on this topic.
With increased experience, physicians are discovering ways to use the IC-8 Apthera IOL (Bausch + Lomb) off label. Two of these physicians discussed their experience using the lens, including ways that it can apply to patients who previously had limited options, particularly those with irregular astigmatism.
When planning cataract surgery, it’s important to pay particular attention to patients who may have a compromised cornea or endothelial damage. Two cornea specialists spoke with EyeWorld about considerations for cataract surgery in these eyes.
➤ FDA approves robotic OCT color fundus camera with OCTA ➤ Company to begin Phase 3 trial for Stargardt macular degeneration treatment ➤ 24-month results of oral treatment for geographic atrophy ➤ Positive Phase 2 results for investigational choroidal melanoma treatment ➤ Partnership news ➤ ASCRS news and events
➤ Whole-eye transplant 1 year later ➤ Phase 3 trial investigating new presbyopia drop therapy begins ➤ Study reports on multi-interventional glaucoma technique ➤ Topline results from Phase 3 trial for drug for active thyroid eye disease ➤ Pilot study complete for AMD treatment ➤ ASCRS news and events
➤ Rare Pediatric Disease designations granted for gene therapies ➤ Tentative FDA approval granted to generic drop for eye redness ➤ Acquisition news ➤ ASCRS news and events
➤ FDA approves expanded access for retinitis pigmentosa gene therapy ➤ Generic steroid receives FDA approval for inflammation ➤ AI-powered smart glasses provide visual help to patients with AMD ➤ ASCRS news and events
➤ FDA 510(k) clearance granted to cataract surgery system ➤ Laser for POAG receives CE Mark ➤ Collaboration to develop dry eye treatment ➤ First patients enrolled in Phase 3 wet AMD trial ➤ New open-access textbook on lens power calculations ➤ ASCRS news and events
In this op-ed, Vance Thompson, MD, Chair of the ASCRS Business of Refractive Cataract Surgery Summit (BRiCS), discussed the opportunities that practices have with advanced-technology IOLs and how BRiCS will give practice teams the confidence they need to increase growth in these IOLs.
“My eyes are irritated … they weren’t before cataract surgery.” “My vision fluctuates … it goes in and out.” These just a couple of phrases an ophthalmologist might hear when ABMD is missed prior to cataract surgery, causing them to wish they had found and treated it preoperatively.